SELLAS Life Sciences Group Financial Overview
SELLAS Life Sciences Group's market cap is currently $259.24M. The company's EPS TTM is $-0.06; its P/E ratio is ―; SELLAS Life Sciences Group is scheduled to report earnings on November 12, 2025, and the estimated EPS forecast is $-0.07. See an overview of income statement, balance sheet, and cash flow financials.
